Orthopedic stem cell therapy is being studied for its potential role in supporting the body's natural repair processes through cellular signaling, inflamma
> Last reviewed: January 2026 — references verified for accuracy and currency.
Orthopedic stem cell therapy has become an area of growing interest in joint preservation as more adults seek options that may support tissue repair while maintaining mobility. In the past, treatment for cartilage damage, tendon injury, or early osteoarthritis often focused primarily on symptom control or surgical intervention. By 2026, regenerative medicine research continues to explore how biologic therapies may support the body's natural healing response in carefully selected patients.
This article explains what orthopedic stem cells are, how joint degeneration develops with age, the different types of regenerative approaches currently discussed in musculoskeletal care, and what individuals can realistically expect from treatment.
Orthopedic stem cell therapy refers to regenerative treatment approaches that use biologic cells-often derived from the patient's own body-to support tissue repair in joints, tendons, ligaments, or cartilage.
In musculoskeletal medicine, the most commonly discussed cell types include mesenchymal stem cells (MSCs), which are typically obtained from bone marrow or adipose (fat) tissue. These cells are studied for their potential to:
It is important to understand that stem cell therapy in orthopedics is considered an evolving area of medicine. Clinical outcomes vary depending on the condition being treated, patient selection, and regulatory standards governing cell processing and use.
Joints such as the knee, hip, and shoulder are responsible for absorbing load and allowing smooth movement. Cartilage, ligaments, and supporting soft tissues work together to maintain stability and function.
As the body ages, cartilage becomes thinner, hydration decreases, and the natural repair response slows. When degeneration progresses, patients may experience:
Preserving joint structure is a key goal in modern orthopedic care.
In older adults, joint changes often develop gradually rather than from a single traumatic injury. Contributing factors may include:
Over time, cartilage may thin and joint surfaces may become less smooth, contributing to osteoarthritis.
Bone Marrow–Derived Cell Therapy – Cells are typically collected from the pelvic bone, processed, and then injected into the affected joint.
Adipose-Derived Cell Therapy – Adipose (fat) tissue can be harvested through minimally invasive techniques.
Platelet-Rich Plasma (PRP) – Uses concentrated platelets from the patient's blood to deliver growth factors to injured tissue.
Each approach must comply with national healthcare regulations.
Weeks 0–2 – Activity modification and protection of the treated area.
Weeks 2–6 – Gradual reintroduction of controlled movement and guided physical therapy.
Months 2–6 – Progressive strengthening and functional rehabilitation.
Regenerative treatments require time for biological processes to occur. Improvements, when they occur, are often gradual rather than immediate.
_All references reviewed January 2026 for accuracy and accessibility._
Orthopedic stem cell therapy is an evolving area within regenerative medicine aimed at supporting joint preservation and tissue repair in selected patients.